Bergua Burgués, Juan Miguel | Hematología y Hemoterapia |

Resultados: 230
Tipo Título / Nombre Autor(es) Año
Outcomes after intensive chemotherapy for secondary and myeloidrelated changes acute myeloid leukemia patients aged 60 to 75 years old: a retrospective analysis from the PETHEMA registry Martínez-Cuadrón D, Megías-Vericat JE, Gil C, Bernal T, Tormo M..., Bergua J 2024
Incidence, risk factors and outcomes od second neoplasm in patients with acute promyelocytic leukemia: the PETHEMA -PALG experience Sobas M, Knopinska-Posluszny W, Pi?tkowska-Jakubas B..., Bergua Burgues JM 2023
AML-443 Clonal Evolution Analysis Using Next Generation Sequencing (NGS) Panel in a Cohort of 3,025 Patients With Acute Myeloid Leukemia (AML) Colmenares R, Sargas C..., Bergua Burgues JM 2023
FLT3-ITP mutation characterization with classical PCR methodology versus capture and amplicon based NGS platforms: a PETHEMA NGS-AML project Bilbao C, Stuckey R..., Bergua Burgues JM 2023
Safety and efficacy of LP-108 as monotherapy and combined with azacitidine in patients with relapsed/refractory myelodysplastic syndromes, chronic myelomonocytic leukemia, or acute myeloid leukemia Koenig K, Bergua Burgues JM, Montesinos P..., Curran E 2023
Covalent Menin Inhibitor Bmf-219 in Patients with Relapsed or Refractory (R/R) Acute Leukemia (AL): Preliminary Phase 1 Data from the Covalent-101 Study Lancet J, Ravandi F, Monteseinos P..., Bergua Burgues JM 2023
Data-Driven Multiparameter Flow Cytometry (MFC) Classification of Blast Differentiation in Elderly Patients with Acute Myeloid Leukemia (AML) González C, Simoes, Ariceta B, Martínez-Cuadron D..., Bergua Burgues JM 2023
The FLT3-like Gene Expression Signature Predicts Response to Quizartinib in Wild-Type FLT3 Acute Myeloid Leukemia: An Analysis of the Pethema Quiwi Trial Mosquera Orgueira A, Pérez Encinas M, Díaz Arias JA..., Bergua Burgues JM 2023
Exploring Potential Molecular Mechanisms of Drug Response in FLT3-ITD Negative AML Patients Treated with Quizartinib Vs Placebo Plus Standard Chemotherapy in the Quiwi Trial Mosquera Orgueira A, Pérez Encinas M, Díaz Arias JA..., Bergua Burgues JM 2023
Treatment Outcomes in Unfit Patients with Newly Acute Myeloid Leukemia According to IDH1 Mutational Status: Real World Evidence from the Pethema Epidemiologic Registry Martínez-Cuadron D, Boluda B, Lorenzo Algarra J..., Bergua Burgues JM 2023